Please provide your email address to receive an email when new articles are posted on . RAS blockers had similar mortality benefit by race in patients with HFrEF. RAS blockers improved HF ...
Please provide your email address to receive an email when new articles are posted on . Diuretics in combination with renin-angiotensin system inhibitors may slow chronic kidney disease on top of ...
Key parameters that influence surgical strategy in localised kidney cancer. Association of ACEI/ARB with tumor regression.
Cost-effectiveness of NALIRIFOX compared to other first-line treatments for metastatic pancreatic cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This ...
In patients with mild or moderate chronic kidney disease, renin–angiotensin system inhibitors have improved outcomes, but less evidence supports their use in advanced CKD. New research findings are ...
March 23, 2012 — Results of a small study provide more evidence that antihypertensive therapy with angiotensin-receptor blockers (ARBs) has benefits on cognitive function in older adults with early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results